| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | galactoside binding | 2.79e-06 | 9 | 248 | 4 | GO:0016936 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 2.21e-05 | 28 | 248 | 5 | GO:0005251 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.21e-05 | 28 | 248 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | disaccharide binding | 6.39e-05 | 7 | 248 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 8.97e-05 | 114 | 248 | 8 | GO:0004843 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYO1A PSG5 ADCY8 ASPM IQGAP3 CACNA1S RASGRF2 USP6 MYO1F MYH15 TRPV4 | 1.50e-04 | 230 | 248 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 1.50e-04 | 9 | 248 | 3 | GO:0017151 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 1.61e-04 | 124 | 248 | 8 | GO:0101005 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 1.68e-04 | 66 | 248 | 6 | GO:0005080 | |
| GeneOntologyMolecularFunction | retinoid binding | 3.14e-04 | 48 | 248 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 3.19e-04 | 137 | 248 | 8 | GO:0019783 | |
| GeneOntologyMolecularFunction | channel activity | SLC17A3 TRPM7 TRPC5 BAK1 CCT8L2 KCNA1 KCNA2 KCNA3 KCNA4 KCNA6 CLCN4 TOMM40L PKD1 CACNA1S TPTE2 TMEM63C TRPV4 | 3.23e-04 | 525 | 248 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC17A3 TRPM7 TRPC5 BAK1 CCT8L2 KCNA1 KCNA2 KCNA3 KCNA4 KCNA6 CLCN4 TOMM40L PKD1 CACNA1S TPTE2 TMEM63C TRPV4 | 3.30e-04 | 526 | 248 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.47e-04 | 49 | 248 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 3.83e-04 | 12 | 248 | 3 | GO:0070410 | |
| GeneOntologyMolecularFunction | F-box domain binding | 4.57e-04 | 3 | 248 | 2 | GO:1990444 | |
| GeneOntologyMolecularFunction | kinase binding | PSG5 RPS3 PPP1R12B SHC3 PKD1 FAM83D PLCB4 HDAC5 UGT1A10 UGT1A8 UGT1A7 POLR2A UGT1A9 NBEA GSK3A PRKAG3 CSPG4 PAM TRPV4 PRKN MYOM2 FCRL5 SMAD1 SMAD3 TP73 | 4.57e-04 | 969 | 248 | 25 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase binding | PSG5 RPS3 PPP1R12B SHC3 PKD1 FAM83D PLCB4 HDAC5 UGT1A10 UGT1A8 UGT1A7 UGT1A9 NBEA GSK3A PRKAG3 CSPG4 PAM TRPV4 PRKN FCRL5 SMAD1 SMAD3 TP73 | 5.83e-04 | 873 | 248 | 23 | GO:0019901 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SLC17A3 TRPM7 TRPC5 CCT8L2 KCNA1 KCNA2 KCNA3 KCNA4 KCNA6 CLCN4 PKD1 CACNA1S TPTE2 TMEM63C TRPV4 | 6.57e-04 | 459 | 248 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | SMAD binding | 7.09e-04 | 86 | 248 | 6 | GO:0046332 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 8.98e-04 | 35 | 248 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | B4GALT2 POGLUT3 ALG6 C1GALT1C1L UGT1A10 UGT1A8 UGT1A7 UGT1A9 GALNTL5 TNKS TNKS2 | 9.96e-04 | 288 | 248 | 11 | GO:0016757 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.13e-03 | 17 | 248 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | I-SMAD binding | 1.13e-03 | 17 | 248 | 3 | GO:0070411 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | PALD1 ACP2 MTMR1 PTPN4 PTPN12 PLCB4 PLD1 ACP7 TPTE2 PPEF1 PPP2R5D PPA2 SMPD2 | 1.14e-03 | 386 | 248 | 13 | GO:0042578 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPM7 TRPC5 CCT8L2 KCNA1 KCNA2 KCNA3 KCNA4 KCNA6 PKD1 CACNA1S TMEM63C TRPV4 | 1.27e-03 | 343 | 248 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | oligosaccharide binding | 1.85e-03 | 20 | 248 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.03e-03 | 182 | 248 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.17e-03 | 184 | 248 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | porin activity | 2.23e-03 | 6 | 248 | 2 | GO:0015288 | |
| GeneOntologyMolecularFunction | osmosensor activity | 2.23e-03 | 6 | 248 | 2 | GO:0005034 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.23e-03 | 6 | 248 | 2 | GO:1905030 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 8.86e-08 | 5 | 240 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 2.63e-07 | 6 | 240 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 2.63e-07 | 6 | 240 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 2.63e-07 | 6 | 240 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.12e-06 | 47 | 240 | 7 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 2.27e-06 | 52 | 240 | 7 | GO:0031342 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 3.55e-06 | 10 | 240 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 3.55e-06 | 10 | 240 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 6.17e-06 | 4 | 240 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 8.41e-06 | 63 | 240 | 7 | GO:0007157 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.18e-05 | 13 | 240 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.53e-05 | 5 | 240 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | LGALS9C LGALS9B PSG5 FGL2 TNFSF4 FER TAP1 LGALS9 MUC4 NCKAP1L | 2.57e-05 | 166 | 240 | 10 | GO:0002698 |
| GeneOntologyBiologicalProcess | liver development | PSG5 MET PKD1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 IGF2R CSNK2A2 SMARCA4 SMAD3 | 2.60e-05 | 202 | 240 | 11 | GO:0001889 |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | PSG5 MET PKD1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 IGF2R CSNK2A2 SMARCA4 SMAD3 | 2.98e-05 | 205 | 240 | 11 | GO:0061008 |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 3.72e-05 | 33 | 240 | 5 | GO:0010818 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 3.78e-05 | 17 | 240 | 4 | GO:0043301 | |
| GeneOntologyBiologicalProcess | SMAD protein signal transduction | 4.42e-05 | 110 | 240 | 8 | GO:0060395 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 5.18e-05 | 83 | 240 | 7 | GO:0002707 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | LGALS9C ARHGAP32 LGALS9B ELP6 F2RL1 F7 TNFSF4 MET PIK3CG FER PLD1 SEMA4A PLP1 ALOX12 CXCR3 LGALS9 ARHGAP5 NUS1 MYO1F TRPV4 SMAD3 NCKAP1L | 5.98e-05 | 742 | 240 | 22 | GO:0040017 |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 6.04e-05 | 19 | 240 | 4 | GO:1900426 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | LGALS9C ARHGAP32 LGALS9B ELP6 F2RL1 F7 TNFSF4 MET PIK3CG FER PLD1 SEMA4A PLP1 ALOX12 LGALS9 ARHGAP5 NUS1 MYO1F TRPV4 SMAD3 NCKAP1L | 6.24e-05 | 691 | 240 | 21 | GO:0030335 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 8.34e-05 | 8 | 240 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 9.16e-05 | 21 | 240 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 9.16e-05 | 21 | 240 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 9.66e-05 | 40 | 240 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.03e-04 | 124 | 240 | 8 | GO:0001910 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.09e-04 | 41 | 240 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | LGALS9C LGALS9B PSG5 FGL2 TNFSF4 FER TAP1 LGALS9 FCRLB MUC4 NCKAP1L | 1.19e-04 | 239 | 240 | 11 | GO:0050777 |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | LGALS9C ARHGAP32 LGALS9B ELP6 F2RL1 F7 TNFSF4 MET PIK3CG FER PLD1 SEMA4A PLP1 ALOX12 LGALS9 ARHGAP5 NUS1 MYO1F TRPV4 SMAD3 NCKAP1L | 1.22e-04 | 725 | 240 | 21 | GO:2000147 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.31e-04 | 96 | 240 | 7 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of chemotaxis | LGALS9C LGALS9B F2RL1 F7 MET MPP1 CXCR3 LGALS9 TRPV4 SMAD3 NCKAP1L | 1.32e-04 | 242 | 240 | 11 | GO:0050920 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | LGALS9C PRTG LGALS9B PSG5 RPS3 HLA-DQA1 HLA-DQA2 CDH23 ADGRV1 TENM2 FGL2 TNFSF4 PIK3CG CNTN5 PKD1 FER ALOX12 CDON VMP1 CBLN1 LGALS9 TENM3 SMARCA4 ASTN1 TRPV4 MUC4 NCKAP1L | 1.49e-04 | 1077 | 240 | 27 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | RPS3 F2RL1 MET FER BAIAP2L2 DYNC1H1 FHOD1 TRPV4 SMAD3 NCKAP1L | 1.51e-04 | 205 | 240 | 10 | GO:0051495 |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGAP32 SIPA1L3 F2RL1 RABL3 MET PIK3CG CDON IQSEC3 RASGRF2 DGKZ OPHN1 ARHGAP5 SOS2 | 1.52e-04 | 333 | 240 | 13 | GO:0051056 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | RPS3 F2RL1 MET PKD1 FER BAIAP2L2 DYNC1H1 EML4 TRIOBP DNAI3 GSK3A FHOD1 MYO1F PAM TRPV4 PRKN SMAD3 NCKAP1L | 1.60e-04 | 579 | 240 | 18 | GO:0051493 |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 1.71e-04 | 45 | 240 | 5 | GO:0045920 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | LGALS9C LGALS9B PSG5 HLA-DQA1 HLA-DQA2 FGL2 TNFSF4 ALOX12 LGALS9 TRPV4 MUC4 | 1.89e-04 | 252 | 240 | 11 | GO:0022408 |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 2.19e-04 | 26 | 240 | 4 | GO:1900424 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 2.19e-04 | 26 | 240 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 2.19e-04 | 26 | 240 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 2.33e-04 | 48 | 240 | 5 | GO:0032733 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte migration | 2.57e-04 | 179 | 240 | 9 | GO:0002687 | |
| GeneOntologyBiologicalProcess | leukocyte degranulation | 2.72e-04 | 108 | 240 | 7 | GO:0043299 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte chemotaxis | 2.76e-04 | 143 | 240 | 8 | GO:0002688 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | LGALS9C LGALS9B HLA-DQA1 HLA-DQA2 TNFSF4 LGALS9 SMARCA4 NCKAP1L | 2.89e-04 | 144 | 240 | 8 | GO:0045582 |
| GeneOntologyBiologicalProcess | regulation of leukocyte migration | LGALS9C LGALS9B F2RL1 F7 TNFSF4 MPP1 CXCR3 LGALS9 MYO1F TRPV4 NCKAP1L | 3.10e-04 | 267 | 240 | 11 | GO:0002685 |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 3.17e-04 | 12 | 240 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | LGALS9C LGALS9B HLA-DQA1 HLA-DQA2 FGL2 TNFSF4 LGALS9 SMARCA4 SOS2 NCKAP1L | 3.30e-04 | 226 | 240 | 10 | GO:0045580 |
| GeneOntologyBiologicalProcess | regulation of cell killing | 3.32e-04 | 147 | 240 | 8 | GO:0031341 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 3.42e-04 | 80 | 240 | 6 | GO:2000179 | |
| GeneOntologyBiologicalProcess | T cell migration | 3.65e-04 | 81 | 240 | 6 | GO:0072678 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 3.72e-04 | 53 | 240 | 5 | GO:0048247 | |
| GeneOntologyBiologicalProcess | chemotaxis | LGALS9C LGALS9B F2RL1 F7 MET PIK3CG FER PLD1 SEMA4A MPP1 CXCR3 LGALS9 LRP2 TRPV4 SMAD3 NCKAP1L | 3.88e-04 | 517 | 240 | 16 | GO:0006935 |
| GeneOntologyBiologicalProcess | response to mycotoxin | 4.01e-04 | 3 | 240 | 2 | GO:0010046 | |
| GeneOntologyBiologicalProcess | taxis | LGALS9C LGALS9B F2RL1 F7 MET PIK3CG FER PLD1 SEMA4A MPP1 CXCR3 LGALS9 LRP2 TRPV4 SMAD3 NCKAP1L | 4.05e-04 | 519 | 240 | 16 | GO:0042330 |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 4.07e-04 | 54 | 240 | 5 | GO:0045066 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 4.08e-04 | 13 | 240 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | RPS3 BAK1 F2RL1 MET FER ANAPC5 BAIAP2L2 DYNC1H1 GSK3A FHOD1 TRPV4 PRKN TNKS CERS1 TNKS2 SMAD3 NCKAP1L | 4.24e-04 | 574 | 240 | 17 | GO:0010638 |
| GeneOntologyBiologicalProcess | positive regulation of chemokine production | 4.45e-04 | 84 | 240 | 6 | GO:0032722 | |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | LGALS9C LGALS9B PSG5 RPS3 HLA-DQA1 HLA-DQA2 TNFSF4 LGALS9 SOS2 NCKAP1L | 4.65e-04 | 236 | 240 | 10 | GO:0042129 |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 4.98e-04 | 32 | 240 | 4 | GO:1903306 | |
| GeneOntologyBiologicalProcess | positive regulation of supramolecular fiber organization | 5.00e-04 | 196 | 240 | 9 | GO:1902905 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 5.15e-04 | 14 | 240 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | T cell differentiation | LGALS9C LGALS9B HLA-DQA1 HLA-DQA2 RABL3 FGL2 TNFSF4 USP44 SEMA4A LGALS9 SMARCA4 SOS2 NCKAP1L | 5.68e-04 | 382 | 240 | 13 | GO:0030217 |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-6 production | 5.70e-04 | 122 | 240 | 7 | GO:0032755 | |
| GeneOntologyBiologicalProcess | chromosome separation | 5.70e-04 | 88 | 240 | 6 | GO:0051304 | |
| GeneOntologyBiologicalProcess | T cell proliferation | LGALS9C LGALS9B PSG5 RPS3 HLA-DQA1 HLA-DQA2 TNFSF4 PIK3CG LGALS9 SOS2 NCKAP1L | 5.85e-04 | 288 | 240 | 11 | GO:0042098 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 6.30e-04 | 34 | 240 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | LGALS9C LGALS9B HLA-DQA1 HLA-DQA2 TNFSF4 LGALS9 SMARCA4 NCKAP1L | 6.35e-04 | 162 | 240 | 8 | GO:0045621 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 6.38e-04 | 15 | 240 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 6.38e-04 | 15 | 240 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | 6.59e-04 | 125 | 240 | 7 | GO:0016579 | |
| GeneOntologyBiologicalProcess | positive regulation of chemotaxis | 7.45e-04 | 166 | 240 | 8 | GO:0050921 | |
| GeneOntologyBiologicalProcess | regulation protein catabolic process at presynapse | 7.97e-04 | 4 | 240 | 2 | GO:0140251 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 8.30e-04 | 63 | 240 | 5 | GO:0043300 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 8.73e-04 | 37 | 240 | 4 | GO:0033081 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-6 production | 8.76e-04 | 212 | 240 | 9 | GO:0032675 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 9.04e-04 | 171 | 240 | 8 | GO:0050868 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | LGALS9C ARHGAP32 LGALS9B PSG5 ELP6 F2RL1 F7 TNFSF4 MET PIK3CG FER PLD1 SEMA4A PLP1 ALOX12 MPP1 CXCR3 HDAC5 DNAI3 LGALS9 ARHGAP5 NUS1 MYO1F SMARCA4 TRPV4 SMAD3 NCKAP1L | 9.19e-04 | 1211 | 240 | 27 | GO:0030334 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | RPS3 BAK1 F2RL1 USP44 MET PKD1 FER ANAPC5 BAIAP2L2 DYNC1H1 MOS EML4 TRIOBP DNAI3 CBLN1 GSK3A KLHL22 CSNK2A2 FHOD1 MYO1F SMARCA4 PAM TRPV4 PRKN TNKS CERS1 TNKS2 SMAD3 NCKAP1L | 9.64e-04 | 1342 | 240 | 29 | GO:0033043 |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 9.67e-04 | 38 | 240 | 4 | GO:0001779 | |
| GeneOntologyBiologicalProcess | regulation of mitophagy | 9.67e-04 | 38 | 240 | 4 | GO:1901524 | |
| GeneOntologyBiologicalProcess | regulation of cell development | LGALS9C SETD1A ARHGAP32 PRTG LGALS9B PSG5 ACHE HLA-DQA1 HLA-DQA2 TRPC5 FGL2 TNFSF4 MET ASPM CDON HDAC5 GSK3A LGALS9 HLTF LRP2 SMARCA4 KDM4A TP73 SOS2 NCKAP1L | 1.03e-03 | 1095 | 240 | 25 | GO:0060284 |
| GeneOntologyBiologicalProcess | chemokine production | 1.04e-03 | 135 | 240 | 7 | GO:0032602 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 8.74e-05 | 8 | 247 | 3 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 1.84e-04 | 10 | 247 | 3 | GO:0071141 | |
| Domain | K_chnl_volt-dep_Kv1 | 2.02e-08 | 8 | 245 | 5 | IPR003972 | |
| Domain | Ion_trans_dom | TRPM7 TRPC5 KCNA1 KCNA2 KCNA3 KCNA4 KCNA6 CACNA1S TPTE2 TRPV4 | 2.59e-06 | 114 | 245 | 10 | IPR005821 |
| Domain | Ion_trans | TRPM7 TRPC5 KCNA1 KCNA2 KCNA3 KCNA4 KCNA6 CACNA1S TPTE2 TRPV4 | 2.59e-06 | 114 | 245 | 10 | PF00520 |
| Domain | IQ | 3.66e-06 | 93 | 245 | 9 | PS50096 | |
| Domain | - | 9.28e-06 | 57 | 245 | 7 | 1.20.120.350 | |
| Domain | Channel_four-helix_dom | 9.28e-06 | 57 | 245 | 7 | IPR027359 | |
| Domain | - | 1.09e-05 | 39 | 245 | 6 | 2.120.10.30 | |
| Domain | YD | 2.19e-05 | 5 | 245 | 3 | IPR006530 | |
| Domain | K_chnl_volt-dep_Kv | 2.38e-05 | 27 | 245 | 5 | IPR003968 | |
| Domain | IQ_motif_EF-hand-BS | 2.40e-05 | 90 | 245 | 8 | IPR000048 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.89e-05 | 46 | 245 | 6 | IPR011042 | |
| Domain | HELP | 4.33e-05 | 6 | 245 | 3 | PF03451 | |
| Domain | HELP | 4.33e-05 | 6 | 245 | 3 | IPR005108 | |
| Domain | VG_K_chnl | 6.56e-05 | 33 | 245 | 5 | IPR028325 | |
| Domain | DWB | 1.19e-04 | 8 | 245 | 3 | SM00524 | |
| Domain | MH2 | 1.19e-04 | 8 | 245 | 3 | PS51076 | |
| Domain | MH1 | 1.19e-04 | 8 | 245 | 3 | PS51075 | |
| Domain | - | 1.19e-04 | 8 | 245 | 3 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 1.19e-04 | 8 | 245 | 3 | IPR013019 | |
| Domain | Dwarfin | 1.19e-04 | 8 | 245 | 3 | IPR013790 | |
| Domain | MH2 | 1.19e-04 | 8 | 245 | 3 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 1.19e-04 | 8 | 245 | 3 | IPR001132 | |
| Domain | UDPGT | 1.45e-04 | 21 | 245 | 4 | PF00201 | |
| Domain | UDP_glucos_trans | 1.45e-04 | 21 | 245 | 4 | IPR002213 | |
| Domain | UDPGT | 1.45e-04 | 21 | 245 | 4 | PS00375 | |
| Domain | USP_CS | 2.26e-04 | 66 | 245 | 6 | IPR018200 | |
| Domain | USP_1 | 3.12e-04 | 70 | 245 | 6 | PS00972 | |
| Domain | IQ | 3.37e-04 | 71 | 245 | 6 | PF00612 | |
| Domain | UCH | 3.37e-04 | 71 | 245 | 6 | PF00443 | |
| Domain | USP_2 | 3.37e-04 | 71 | 245 | 6 | PS00973 | |
| Domain | USP_dom | 3.63e-04 | 72 | 245 | 6 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 3.63e-04 | 72 | 245 | 6 | IPR001394 | |
| Domain | USP_3 | 3.63e-04 | 72 | 245 | 6 | PS50235 | |
| Domain | MAD_homology1_Dwarfin-type | 4.49e-04 | 12 | 245 | 3 | IPR003619 | |
| Domain | DWA | 4.49e-04 | 12 | 245 | 3 | SM00523 | |
| Domain | MH1 | 4.49e-04 | 12 | 245 | 3 | PF03165 | |
| Domain | - | CFAP251 EML6 WDR76 BRWD3 MET EML5 NLE1 SEMA4A BRWD1 EML4 NBEA DNAI3 WDR82 | 4.79e-04 | 333 | 245 | 13 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | CFAP251 EML6 WDR76 BRWD3 MET EML5 NLE1 SEMA4A BRWD1 EML4 NBEA DNAI3 WDR82 | 5.06e-04 | 335 | 245 | 13 | IPR015943 |
| Domain | Rhs_assc_core | 5.10e-04 | 3 | 245 | 2 | IPR022385 | |
| Domain | PH_dom-like | RGPD4 MTMR1 SHC3 PTPN4 RGPD3 PLCB4 PLD1 IQSEC3 RASGRF2 FRMPD1 TRIOBP NBEA OPHN1 MYLIP SOS2 | 5.31e-04 | 426 | 245 | 15 | IPR011993 |
| Domain | NHL | 5.79e-04 | 13 | 245 | 3 | PS51125 | |
| Domain | WD40_repeat_dom | CFAP251 EML6 WDR76 BRWD3 EML5 NLE1 BRWD1 EML4 NBEA DNAI3 TENM3 WDR82 | 5.81e-04 | 297 | 245 | 12 | IPR017986 |
| Domain | T1-type_BTB | 6.40e-04 | 53 | 245 | 5 | IPR003131 | |
| Domain | BTB_2 | 6.40e-04 | 53 | 245 | 5 | PF02214 | |
| Domain | WD40 | CFAP251 EML6 WDR76 BRWD3 EML5 NLE1 BRWD1 EML4 NBEA DNAI3 WDR82 | 6.49e-04 | 259 | 245 | 11 | PF00400 |
| Domain | IQ | 6.84e-04 | 81 | 245 | 6 | SM00015 | |
| Domain | Ldl_recept_b | 7.29e-04 | 14 | 245 | 3 | PF00058 | |
| Domain | LDLRB | 7.29e-04 | 14 | 245 | 3 | PS51120 | |
| Domain | WD40 | CFAP251 EML6 WDR76 BRWD3 EML5 NLE1 BRWD1 EML4 NBEA DNAI3 WDR82 | 8.60e-04 | 268 | 245 | 11 | SM00320 |
| Domain | Galectin_CRD | 9.03e-04 | 15 | 245 | 3 | IPR001079 | |
| Domain | LY | 9.03e-04 | 15 | 245 | 3 | SM00135 | |
| Domain | Gal-bind_lectin | 9.03e-04 | 15 | 245 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 9.03e-04 | 15 | 245 | 3 | SM00908 | |
| Domain | GALECTIN | 9.03e-04 | 15 | 245 | 3 | PS51304 | |
| Domain | LDLR_classB_rpt | 9.03e-04 | 15 | 245 | 3 | IPR000033 | |
| Domain | GLECT | 9.03e-04 | 15 | 245 | 3 | SM00276 | |
| Domain | WD40_repeat | CFAP251 EML6 WDR76 BRWD3 EML5 NLE1 BRWD1 EML4 NBEA DNAI3 WDR82 | 9.70e-04 | 272 | 245 | 11 | IPR001680 |
| Domain | Tox-GHH_dom | 1.01e-03 | 4 | 245 | 2 | IPR028916 | |
| Domain | Tox-GHH | 1.01e-03 | 4 | 245 | 2 | PF15636 | |
| Domain | Ten_N | 1.01e-03 | 4 | 245 | 2 | PF06484 | |
| Domain | TENEURIN_N | 1.01e-03 | 4 | 245 | 2 | PS51361 | |
| Domain | Ten_N | 1.01e-03 | 4 | 245 | 2 | IPR009471 | |
| Domain | SMAD_dom-like | 1.10e-03 | 16 | 245 | 3 | IPR017855 | |
| Domain | - | 1.10e-03 | 16 | 245 | 3 | 2.60.200.10 | |
| Domain | WD_REPEATS_1 | CFAP251 EML6 WDR76 BRWD3 EML5 NLE1 BRWD1 EML4 NBEA DNAI3 WDR82 | 1.16e-03 | 278 | 245 | 11 | PS00678 |
| Domain | WD_REPEATS_2 | CFAP251 EML6 WDR76 BRWD3 EML5 NLE1 BRWD1 EML4 NBEA DNAI3 WDR82 | 1.19e-03 | 279 | 245 | 11 | PS50082 |
| Domain | WD_REPEATS_REGION | CFAP251 EML6 WDR76 BRWD3 EML5 NLE1 BRWD1 EML4 NBEA DNAI3 WDR82 | 1.19e-03 | 279 | 245 | 11 | PS50294 |
| Domain | - | 1.33e-03 | 92 | 245 | 6 | 3.90.190.10 | |
| Domain | MYOSIN_MOTOR | 1.50e-03 | 38 | 245 | 4 | PS51456 | |
| Domain | Myosin_head_motor_dom | 1.50e-03 | 38 | 245 | 4 | IPR001609 | |
| Domain | Myosin_head | 1.50e-03 | 38 | 245 | 4 | PF00063 | |
| Domain | MYSc | 1.50e-03 | 38 | 245 | 4 | SM00242 | |
| Domain | - | 1.57e-03 | 95 | 245 | 6 | 2.60.120.200 | |
| Domain | C1-set_C | 1.67e-03 | 5 | 245 | 2 | PF16196 | |
| Domain | NIDO | 1.67e-03 | 5 | 245 | 2 | SM00539 | |
| Domain | MHC_II_alpha | 1.67e-03 | 5 | 245 | 2 | SM00920 | |
| Domain | B56 | 1.67e-03 | 5 | 245 | 2 | PF01603 | |
| Domain | C1-set_C | 1.67e-03 | 5 | 245 | 2 | IPR032431 | |
| Domain | PP2A_B56 | 1.67e-03 | 5 | 245 | 2 | IPR002554 | |
| Domain | NIDO_dom | 1.67e-03 | 5 | 245 | 2 | IPR003886 | |
| Domain | NIDO | 1.67e-03 | 5 | 245 | 2 | PF06119 | |
| Domain | NIDO | 1.67e-03 | 5 | 245 | 2 | PS51220 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.94e-03 | 99 | 245 | 6 | IPR029021 | |
| Domain | - | RGPD4 MTMR1 SHC3 PTPN4 RGPD3 PLCB4 PLD1 IQSEC3 RASGRF2 TRIOBP OPHN1 MYLIP SOS2 | 2.05e-03 | 391 | 245 | 13 | 2.30.29.30 |
| Domain | CP2 | 2.48e-03 | 6 | 245 | 2 | PF04516 | |
| Domain | CP2 | 2.48e-03 | 6 | 245 | 2 | IPR007604 | |
| Domain | - | 2.48e-03 | 6 | 245 | 2 | 2.70.130.10 | |
| Domain | MHC_II_alpha | 2.48e-03 | 6 | 245 | 2 | PF00993 | |
| Domain | BTB | 2.64e-03 | 180 | 245 | 8 | SM00225 | |
| Pubmed | Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly. | 1.14e-10 | 6 | 252 | 5 | 14686897 | |
| Pubmed | Developmental expression of voltage-sensitive K+ channels in mouse skeletal muscle and C2C12 cells. | 4.70e-09 | 10 | 252 | 5 | 1383027 | |
| Pubmed | 1.34e-08 | 5 | 252 | 4 | 10428084 | ||
| Pubmed | 1.34e-08 | 5 | 252 | 4 | 21233214 | ||
| Pubmed | 2.78e-08 | 26 | 252 | 6 | 7905852 | ||
| Pubmed | Physical mapping of potassium channel gene clusters on mouse chromosomes three and six. | 3.99e-08 | 6 | 252 | 4 | 9286706 | |
| Pubmed | 3.99e-08 | 6 | 252 | 4 | 32527940 | ||
| Pubmed | 3.99e-08 | 6 | 252 | 4 | 20297805 | ||
| Pubmed | 3.99e-08 | 6 | 252 | 4 | 8938729 | ||
| Pubmed | 7.86e-08 | 16 | 252 | 5 | 28283561 | ||
| Pubmed | POGLUT3 MAN2B1 RPS3 ACP2 FKBP9 NIF3L1 SMARCAD1 PGD DHX9 MET PTPN12 GLB1 NLE1 PLCB4 TAP1 DYNC1H1 ATRN DNAJC13 IARS1 EEF1E1 POLRMT OSGEP GSK3A PPP2R5D IGF2R SEC24C VANGL1 CSNK2A2 PPA2 | 8.75e-08 | 1297 | 252 | 29 | 33545068 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 9.26e-08 | 7 | 252 | 4 | 8467709 | |
| Pubmed | 9.26e-08 | 7 | 252 | 4 | 7477295 | ||
| Pubmed | 9.26e-08 | 7 | 252 | 4 | 27619418 | ||
| Pubmed | 9.26e-08 | 7 | 252 | 4 | 27514509 | ||
| Pubmed | 9.26e-08 | 7 | 252 | 4 | 23933588 | ||
| Pubmed | 9.26e-08 | 7 | 252 | 4 | 8464825 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.11e-07 | 17 | 252 | 5 | 20639394 | |
| Pubmed | MRPL23 IBA57 POGLUT3 TRPM7 NOC2L MTMR1 SMARCAD1 RABL3 PGD DHX9 MET URB1 GLB1 DHCR7 ASPM NLE1 DNAJC13 DNAJC30 POLRMT TRIOBP EMC9 TARS2 TFCP2 SNX29 RALY PPP2R5D IGF2R SEC24C VANGL1 PPA2 M6PR | 1.43e-07 | 1487 | 252 | 31 | 33957083 | |
| Pubmed | RGPD4 ARHGAP32 SIPA1L3 TENM2 ZNF462 NEFM KCNA1 KCNA2 KCNA3 KCNA4 RGPD3 PLP1 DYNC1H1 IQSEC3 DNAJC13 TRIOBP DGKZ NBEA PPP2R5D IGF2R SEC24C CSNK2A2 SMARCA4 TNKS | 1.77e-07 | 963 | 252 | 24 | 28671696 | |
| Pubmed | 1.84e-07 | 8 | 252 | 4 | 20610558 | ||
| Pubmed | 1.84e-07 | 8 | 252 | 4 | 12435606 | ||
| Pubmed | 1.84e-07 | 8 | 252 | 4 | 18052087 | ||
| Pubmed | 1.84e-07 | 8 | 252 | 4 | 17179145 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MAN2B1 TM9SF3 FKBP9 ELP6 LRP1B MET FAP PTPN12 GLB1 DHCR7 ALG6 TAP1 SLC27A3 CDON VMP1 ATRN EMC9 PLA2R1 USP5 IGF2R SEC24C TENM3 FHOD1 CSPG4 PAM CERS1 M6PR | 2.26e-07 | 1201 | 252 | 27 | 35696571 |
| Pubmed | TRPM7 SIPA1L3 USP25 SMARCAD1 USP9Y LRP1B BRWD3 NEFM PKD1 PLP1 DYNC1H1 VCPIP1 BRWD1 ATRN VPS39 TRIOBP TTC27 NBEA GSK3A ARHGAP5 LRP2 SMARCA4 ASTN1 TNKS KDM4A PALS2 TNKS2 SOS2 | 2.50e-07 | 1285 | 252 | 28 | 35914814 | |
| Pubmed | 3.30e-07 | 9 | 252 | 4 | 22511988 | ||
| Pubmed | High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12. | 3.30e-07 | 9 | 252 | 4 | 16309881 | |
| Pubmed | Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. | 3.30e-07 | 9 | 252 | 4 | 25065622 | |
| Pubmed | 3.30e-07 | 9 | 252 | 4 | 9488722 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 33316546 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 28704475 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 3.76e-07 | 3 | 252 | 3 | 7890611 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 32380082 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 23667648 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 28877989 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 19800850 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 37105392 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 36479526 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 3.76e-07 | 3 | 252 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 3.76e-07 | 3 | 252 | 3 | 33923930 | |
| Pubmed | Human potassium channel genes: Molecular cloning and functional expression. | 3.76e-07 | 3 | 252 | 3 | 19912772 | |
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 3.76e-07 | 3 | 252 | 3 | 31969388 | |
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 3.76e-07 | 3 | 252 | 3 | 23408620 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 3.76e-07 | 3 | 252 | 3 | 29458010 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 26582205 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 9153289 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 23144904 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 21146220 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 29519853 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 16990264 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 18005988 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 23585851 | ||
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 3.76e-07 | 3 | 252 | 3 | 25898318 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 18282810 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 3.76e-07 | 3 | 252 | 3 | 25931247 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 17560833 | ||
| Pubmed | A family of three mouse potassium channel genes with intronless coding regions. | 3.76e-07 | 3 | 252 | 3 | 2305265 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 19776007 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 9038233 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 10428758 | ||
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 3.76e-07 | 3 | 252 | 3 | 22341088 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 38987795 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 17634333 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 3.76e-07 | 3 | 252 | 3 | 35241678 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 22627368 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 33153471 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 22052881 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 12847094 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 35643073 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 18974023 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 3.76e-07 | 3 | 252 | 3 | 29651447 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 3.76e-07 | 3 | 252 | 3 | 28990062 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 18579572 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 3.76e-07 | 3 | 252 | 3 | 29433546 | |
| Pubmed | Cloning, sequence and chromosomal localization of MK6, a murine potassium channel gene. | 3.76e-07 | 3 | 252 | 3 | 1285906 | |
| Pubmed | Clinical spectrum of voltage-gated potassium channel autoimmunity. | 3.76e-07 | 3 | 252 | 3 | 18474843 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 31937306 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 21426359 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 24083426 | ||
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 37279535 | ||
| Pubmed | CLTCL1 RPS3 HLA-DQA1 ACP2 MED14 DHX9 ATP11B PIK3CG DHCR7 PLD1 ALG6 TAP1 DYNC1H1 SLC27A3 MPP1 DNAJC13 EML4 IARS1 IGF2R FHOD1 HLTF SMARCA4 PAM NUP93 M6PR NCKAP1L | 4.63e-07 | 1168 | 252 | 26 | 19946888 | |
| Pubmed | 5.46e-07 | 10 | 252 | 4 | 23642732 | ||
| Pubmed | 5.46e-07 | 10 | 252 | 4 | 11465080 | ||
| Pubmed | 5.46e-07 | 10 | 252 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 5.46e-07 | 10 | 252 | 4 | 22558097 | |
| Pubmed | 1.27e-06 | 12 | 252 | 4 | 21538804 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.27e-06 | 12 | 252 | 4 | 20308471 | |
| Pubmed | 1.27e-06 | 12 | 252 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.27e-06 | 12 | 252 | 4 | 11434514 | |
| Pubmed | 1.50e-06 | 4 | 252 | 3 | 22677125 | ||
| Pubmed | 1.50e-06 | 4 | 252 | 3 | 19234217 | ||
| Pubmed | 1.50e-06 | 4 | 252 | 3 | 35715604 | ||
| Pubmed | 1.50e-06 | 4 | 252 | 3 | 19017954 | ||
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 1.50e-06 | 4 | 252 | 3 | 36459823 | |
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 1.50e-06 | 4 | 252 | 3 | 29611821 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 1.50e-06 | 4 | 252 | 3 | 33727589 | |
| Cytoband | 2q37 | 2.48e-05 | 31 | 252 | 4 | 2q37 | |
| Cytoband | 5q13 | 2.33e-04 | 22 | 252 | 3 | 5q13 | |
| GeneFamily | Ubiquitin specific peptidases | 2.25e-05 | 56 | 185 | 6 | 366 | |
| GeneFamily | Potassium voltage-gated channels | 5.23e-05 | 40 | 185 | 5 | 274 | |
| GeneFamily | SMAD family | 5.68e-05 | 8 | 185 | 3 | 750 | |
| GeneFamily | WD repeat domain containing | CFAP251 EML6 WDR76 BRWD3 EML5 NLE1 BRWD1 EML4 NBEA DNAI3 WDR82 | 8.37e-05 | 262 | 185 | 11 | 362 |
| GeneFamily | UDP glucuronosyltransferases | 3.05e-04 | 32 | 185 | 4 | 363 | |
| GeneFamily | Galectins | 4.38e-04 | 15 | 185 | 3 | 629 | |
| GeneFamily | CD molecules|MRH domain containing | 1.52e-03 | 6 | 185 | 2 | 1233 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.69e-03 | 50 | 185 | 4 | 1293 | |
| GeneFamily | Myosins, class I | 2.80e-03 | 8 | 185 | 2 | 1097 | |
| GeneFamily | Transient receptor potential cation channels | 2.86e-03 | 28 | 185 | 3 | 249 | |
| GeneFamily | Ankyrin repeat domain containing | PPP1R12B ANKRD30B ANKRD36C ANKRD36B ANKRD30A TRPV4 TNKS TNKS2 | 3.53e-03 | 242 | 185 | 8 | 403 |
| GeneFamily | Immunoglobulin like domain containing | 3.77e-03 | 193 | 185 | 7 | 594 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN | ACP2 PIK3CG MPP1 ATRN HDAC5 VPS39 IARS1 EEF1E1 POLR2A AGGF1 PPP2R5C SEC24C MYO1F | 7.13e-08 | 199 | 251 | 13 | M7651 |
| Coexpression | GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN | ACHE CLK4 USP25 MTMR1 PTPN4 PGGHG FRMPD1 KLHL22 ANKRD36B ARHGAP5 CSPG4 | 3.58e-06 | 198 | 251 | 11 | M5448 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | CDH23 GLP2R PLD1 CDON NID2 MXRA5 CFI PLA2R1 TENM3 ENTPD2 ASTN1 ENPEP | 9.86e-10 | 190 | 252 | 12 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.62e-07 | 193 | 252 | 10 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | Sepsis-URO-Myeloid-cDC1|URO / Disease, condition lineage and cell class | PALD1 HLA-DQA1 HLA-DQA2 FGL2 ZNF462 TAP1 CXCR3 ARHGAP5 PPA2 MYH15 | 2.25e-07 | 200 | 252 | 10 | c5ca81218be40b30e2f9252c1a004cb95d988447 |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.57e-07 | 176 | 252 | 9 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.72e-07 | 179 | 252 | 9 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.10e-06 | 199 | 252 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.19e-06 | 149 | 252 | 8 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-06 | 162 | 252 | 8 | ca1014e32996f777bff021830ce9a7cf4acf58d5 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-06 | 164 | 252 | 8 | 7a65c7a6dbe5fb9067f83efafbb7ec8206d79325 | |
| ToppCell | Int-URO-Myeloid-tDC|Int-URO / Disease, Lineage and Cell Type | 4.66e-06 | 165 | 252 | 8 | 9803c3db6cdcf925bea7d9c382bf4fd05acf3509 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.53e-06 | 120 | 252 | 7 | eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1 | |
| ToppCell | URO-Myeloid-cDC1|URO / Disease, Lineage and Cell Type | 6.61e-06 | 173 | 252 | 8 | 57f4e9f39ef6e02dca76f3dd0b39a0871917ed5a | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 6.89e-06 | 174 | 252 | 8 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-06 | 175 | 252 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.81e-06 | 177 | 252 | 8 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.48e-06 | 179 | 252 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.83e-06 | 180 | 252 | 8 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.83e-06 | 180 | 252 | 8 | fb8bc639f7f94e7aed9f9d708d5d5c78178533ae | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.58e-06 | 182 | 252 | 8 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.04e-05 | 184 | 252 | 8 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 252 | 8 | 22fd1959879705a8c1128faa9de66696c4e0b7e3 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 252 | 8 | 5fae538de481367cf6d9a2d52190d77b99f6922c | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 252 | 8 | 0526c0a818cf28fd5b6ff65fe260e3c3a4a98a2a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 190 | 252 | 8 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 190 | 252 | 8 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.47e-05 | 193 | 252 | 8 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | VE-mDC1-|VE / Condition, Cell_class and T cell subcluster | 1.47e-05 | 193 | 252 | 8 | 5df6033bc0e4f96a20d526486a8e89c990e21831 | |
| ToppCell | VE-mDC1|VE / Condition, Cell_class and T cell subcluster | 1.47e-05 | 193 | 252 | 8 | 12b2708db9db8b88365b8ebeb4908f28c50081bb | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.58e-05 | 195 | 252 | 8 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.59e-05 | 141 | 252 | 7 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 196 | 252 | 8 | 9c942bf9fc78caa173d2c7de5fe4c17f076c623b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 196 | 252 | 8 | 787088ce800d7148bad7265a971797da597b029a | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 197 | 252 | 8 | febafd8f0f5bb9a09f496f240e6b6b5e9275669b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-05 | 198 | 252 | 8 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-05 | 198 | 252 | 8 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 199 | 252 | 8 | bfc157be6e9f84739848eb19b718de5b17f3fa88 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-05 | 200 | 252 | 8 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | COVID-19_Moderate-CD4+_CTL|COVID-19_Moderate / disease group, cell group and cell class | 1.89e-05 | 200 | 252 | 8 | a9c73559e2c9fda1b065bfb5ce84978995505924 | |
| ToppCell | Dendritic_Cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.23e-05 | 100 | 252 | 6 | bb7bd11e28be830f381144d4a6f29a86da59d9fa | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.27e-05 | 149 | 252 | 7 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-05 | 156 | 252 | 7 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.28e-05 | 107 | 252 | 6 | 2f84089acc794b43ee59452dc8f90ca7261ebd41 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Lmcd1_(Mural.Rgs5Acta2.Lmcd1)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.28e-05 | 107 | 252 | 6 | 0b45241cc52d10225966b49941efb66997184158 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.58e-05 | 160 | 252 | 7 | 8e2b51d7b42e0b6e62641efdbbc73d31561d6a3e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.58e-05 | 160 | 252 | 7 | 94e4f5fc2156dd8163811c3b8b0781ea9b3f2e06 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-05 | 160 | 252 | 7 | ac3f56f8ab8efd11c4b4868a828db05c23ac762f | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 163 | 252 | 7 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 163 | 252 | 7 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-05 | 165 | 252 | 7 | 361a605d8f833d9ec54b120480dce397da35f9c3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-05 | 166 | 252 | 7 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-05 | 166 | 252 | 7 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.70e-05 | 167 | 252 | 7 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.89e-05 | 168 | 252 | 7 | 907692c1f03d3c9889ba1bed5a4844e2c379db8e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.07e-05 | 169 | 252 | 7 | a0681317867e31319210a23e56660a53f4529efe | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd8+_T_cell)|Lymphoid / shred on cell class and cell subclass (v4) | 5.27e-05 | 170 | 252 | 7 | 20fd1a312c81c1bf3c5d2d6caf9b578e6b7a4171 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 170 | 252 | 7 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.46e-05 | 171 | 252 | 7 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.67e-05 | 172 | 252 | 7 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 5.88e-05 | 173 | 252 | 7 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.88e-05 | 173 | 252 | 7 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-05 | 173 | 252 | 7 | 60e427f6c7d953cef5f692043670ff0b49cdce72 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 174 | 252 | 7 | c92eec5a14ca5269673582dd115ead8516e64c3e | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.10e-05 | 174 | 252 | 7 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.10e-05 | 174 | 252 | 7 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-05 | 175 | 252 | 7 | b85279b9efd72d7074c4226d50ce139a38c0e1c1 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-05 | 175 | 252 | 7 | f7cd2ef79d91d64976fcdb5f1e7343b24ba27456 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 176 | 252 | 7 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 6.55e-05 | 176 | 252 | 7 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.79e-05 | 177 | 252 | 7 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-05 | 177 | 252 | 7 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-05 | 177 | 252 | 7 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.79e-05 | 177 | 252 | 7 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.79e-05 | 177 | 252 | 7 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 6.79e-05 | 177 | 252 | 7 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.04e-05 | 178 | 252 | 7 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.04e-05 | 178 | 252 | 7 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 178 | 252 | 7 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 178 | 252 | 7 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 178 | 252 | 7 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_migrating_neuronal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.04e-05 | 178 | 252 | 7 | 38ffbd01230c99f52274424ee6c172381daffc73 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.29e-05 | 179 | 252 | 7 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | T_cells-GZMK+_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.29e-05 | 179 | 252 | 7 | 798f208014f2229c597934775646ddbbacf94b69 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-05 | 179 | 252 | 7 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Naive_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.55e-05 | 180 | 252 | 7 | 16516dd9c78c27fc76f58d650de9851ffa0763e7 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 7.55e-05 | 180 | 252 | 7 | a0b35067b6f2dbd8145da8bab760e9f650f045b0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 181 | 252 | 7 | 6cdee2f56bc633b387b4dbbd78c624edbd712c24 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.81e-05 | 181 | 252 | 7 | 7679a5980011d6dfb1aaca7abf678c29b6f819bb | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.81e-05 | 181 | 252 | 7 | 3dcb74b28f93be35ddf4de1937f7e30b25e11927 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 181 | 252 | 7 | b75b8b025257bccfe661fd0f92ab284b2a9c12ee | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.09e-05 | 182 | 252 | 7 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.09e-05 | 182 | 252 | 7 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.09e-05 | 182 | 252 | 7 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 252 | 7 | 107cc756c45d6e92181659868d91188814dae66d | |
| ToppCell | Dendritic_Cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.37e-05 | 183 | 252 | 7 | dd09e39e8ca282ff0f470e0652d519e190badd0b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 252 | 7 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 183 | 252 | 7 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 184 | 252 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 184 | 252 | 7 | fea4fe648e9749177d0783443dc26a7df5807883 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue | 8.66e-05 | 184 | 252 | 7 | 09fa465d1852b9b7e0405c27d4e5de276c9ba871 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 184 | 252 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| Drug | retigabine | 5.19e-08 | 48 | 252 | 8 | CID000121892 | |
| Drug | naringenin chalcone | 7.26e-08 | 5 | 252 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 7.26e-08 | 5 | 252 | 4 | ctd:C032186 | |
| Drug | AC1L9HHR | CLTCL1 MYO1A BAK1 F7 ADCY8 FGL2 ATP11B PLD1 PLP1 POLR2A POLRMT DGKZ SYTL4 PRKACG TNKS SMPD2 TNKS2 ENPEP | 9.54e-08 | 354 | 252 | 18 | CID000445141 |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 2.16e-07 | 6 | 252 | 4 | ctd:C543211 | |
| Drug | alloin | 2.16e-07 | 6 | 252 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 2.16e-07 | 6 | 252 | 4 | ctd:C107497 | |
| Drug | propranolol glucuronide | 2.95e-07 | 14 | 252 | 5 | CID000119515 | |
| Drug | 2',4'-dihydroxychalcone | 5.00e-07 | 7 | 252 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 9.91e-07 | 8 | 252 | 4 | ctd:C034890 | |
| Drug | Br 2 | 1.22e-06 | 18 | 252 | 5 | CID003060900 | |
| Drug | ApApG | 1.22e-06 | 18 | 252 | 5 | CID003081975 | |
| Drug | 9-OH-risperidone | 1.64e-06 | 19 | 252 | 5 | CID000475100 | |
| Drug | AC1MRQNQ | 1.77e-06 | 9 | 252 | 4 | CID003522271 | |
| Drug | DHPASiU | 1.77e-06 | 9 | 252 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 1.77e-06 | 9 | 252 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 1.77e-06 | 9 | 252 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 1.77e-06 | 9 | 252 | 4 | CID005460873 | |
| Drug | 2,6-dihydroxyanthraquinone | 2.92e-06 | 10 | 252 | 4 | ctd:C034889 | |
| Drug | UDP-glucose | B4GALT2 MAN2B1 NIF3L1 PGD GLB1 ALG6 TAP1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 PPA2 ENPEP | 4.12e-06 | 247 | 252 | 13 | CID000001166 |
| Drug | 4-nitrophenyl)imidazole | 4.55e-06 | 11 | 252 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 4.55e-06 | 11 | 252 | 4 | CID006442661 | |
| Drug | hydratropic acid | 5.32e-06 | 4 | 252 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 5.32e-06 | 4 | 252 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 5.32e-06 | 4 | 252 | 3 | ctd:C037760 | |
| Drug | N-OH-DABZ | 6.76e-06 | 12 | 252 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 6.76e-06 | 12 | 252 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 6.76e-06 | 12 | 252 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 6.76e-06 | 12 | 252 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 6.76e-06 | 12 | 252 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 6.76e-06 | 12 | 252 | 4 | CID000276709 | |
| Drug | 5-MOP | 7.08e-06 | 25 | 252 | 5 | CID000002355 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | CLTCL1 ACHE PPP1R12B ACP2 ADCY8 FGL2 KCNA3 GLB1 PKD1 PLCB4 ALOX12 CACNA1S COL10A1 POLR2A POLRMT CSNK2A2 FHOD1 PRKACG SMARCA4 TRPV4 | 7.42e-06 | 577 | 252 | 20 | CID000000295 |
| Drug | 2-hydroxyestrone | 9.69e-06 | 13 | 252 | 4 | ctd:C024980 | |
| Drug | tritanol | 9.69e-06 | 13 | 252 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 9.69e-06 | 13 | 252 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 9.69e-06 | 13 | 252 | 4 | CID000000411 | |
| Drug | alizarin | 9.69e-06 | 13 | 252 | 4 | ctd:C010078 | |
| Drug | galangin | 1.02e-05 | 68 | 252 | 7 | ctd:C037032 | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | MTMR1 F2RL1 MET URB1 PTPN12 CLCN4 SEMA4A MPP1 EML4 KLHL22 SOS2 | 1.14e-05 | 194 | 252 | 11 | 7538_DN |
| Drug | DB04103 | 1.25e-05 | 97 | 252 | 8 | CID004469987 | |
| Drug | isovaleric acid | 1.32e-05 | 5 | 252 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 1.32e-05 | 5 | 252 | 3 | ctd:C012776 | |
| Drug | PCB-61 | 1.34e-05 | 14 | 252 | 4 | CID000036401 | |
| Drug | clofilium | 1.79e-05 | 74 | 252 | 7 | CID000002798 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.82e-05 | 15 | 252 | 4 | CID000040469 | |
| Drug | afloqualone | 1.82e-05 | 15 | 252 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 1.82e-05 | 15 | 252 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.82e-05 | 15 | 252 | 4 | CID000010752 | |
| Drug | bergamottin | 1.82e-05 | 15 | 252 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 1.82e-05 | 15 | 252 | 4 | CID000543743 | |
| Drug | lanthanum | 2.13e-05 | 136 | 252 | 9 | CID000023926 | |
| Drug | quercetin-3,4'-diglucoside | 2.40e-05 | 16 | 252 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 2.40e-05 | 16 | 252 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 2.40e-05 | 16 | 252 | 4 | CID005497144 | |
| Drug | NNAL | 2.52e-05 | 32 | 252 | 5 | CID000104856 | |
| Drug | AC1L1B9H | 2.53e-05 | 78 | 252 | 7 | CID000001341 | |
| Drug | DEPC | 2.57e-05 | 53 | 252 | 6 | CID000015357 | |
| Drug | CID10948590 | 2.61e-05 | 6 | 252 | 3 | CID010948590 | |
| Drug | 3-phenylpropionic acid | 2.61e-05 | 6 | 252 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 2.61e-05 | 6 | 252 | 3 | ctd:D007216 | |
| Drug | A-Mate | 2.94e-05 | 33 | 252 | 5 | CID000010944 | |
| Drug | geniposide | 2.94e-05 | 33 | 252 | 5 | CID000107848 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 3.11e-05 | 17 | 252 | 4 | CID000003573 | |
| Drug | tetrapentylammonium | 3.11e-05 | 17 | 252 | 4 | CID000017248 | |
| Drug | 6-hydroxychrysene | 3.11e-05 | 17 | 252 | 4 | CID000037766 | |
| Drug | AC1NOWCJ | 3.95e-05 | 35 | 252 | 5 | CID005120112 | |
| Drug | SureCN12722713 | 3.97e-05 | 18 | 252 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 3.97e-05 | 18 | 252 | 4 | CID000152226 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 3.97e-05 | 18 | 252 | 4 | CID000036614 | |
| Drug | C1 11-32 | 3.97e-05 | 18 | 252 | 4 | CID000443077 | |
| Drug | C11131 | 3.97e-05 | 18 | 252 | 4 | CID000443076 | |
| Drug | acetaminophen glucuronide | 4.78e-05 | 59 | 252 | 6 | CID000083944 | |
| Drug | MW 1 | 4.87e-05 | 151 | 252 | 9 | CID000073965 | |
| Drug | 5alpha-spirostan-3beta-ol | 4.98e-05 | 19 | 252 | 4 | CID000091433 | |
| Drug | almokalant | 4.98e-05 | 19 | 252 | 4 | CID003033962 | |
| Drug | N-Fg | 5.21e-05 | 37 | 252 | 5 | CID000445227 | |
| Drug | l-borneol | 5.21e-05 | 37 | 252 | 5 | CID000010049 | |
| Drug | 3,4-diaminopyridine | 5.95e-05 | 38 | 252 | 5 | CID000005918 | |
| Drug | tectochrysin | 6.18e-05 | 20 | 252 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 6.18e-05 | 20 | 252 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 6.18e-05 | 20 | 252 | 4 | CID000116545 | |
| Drug | entacapone | 6.18e-05 | 20 | 252 | 4 | ctd:C071192 | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A | 6.68e-05 | 195 | 252 | 10 | 2708_DN | |
| Drug | glabridin | 7.20e-05 | 8 | 252 | 3 | ctd:C107601 | |
| Drug | estriol-16-glucuronide | 7.56e-05 | 21 | 252 | 4 | CID000122281 | |
| Drug | dulcin | 7.56e-05 | 21 | 252 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 7.56e-05 | 21 | 252 | 4 | CID000069186 | |
| Drug | 5255229; Down 200; 13uM; MCF7; HT_HG-U133A_EA | B4GALT2 CLK4 SLC41A3 NLE1 ANAPC5 VCPIP1 BRWD1 TRIOBP SMAD5 SOS2 | 7.59e-05 | 198 | 252 | 10 | 833_DN |
| Drug | amonafide | 9.16e-05 | 22 | 252 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 9.16e-05 | 22 | 252 | 4 | CID000053167 | |
| Drug | plumbagin | 9.16e-05 | 22 | 252 | 4 | ctd:C014758 | |
| Drug | PTBP | 9.72e-05 | 42 | 252 | 5 | CID000007393 | |
| Drug | AC1NFJIQ | 9.72e-05 | 42 | 252 | 5 | CID004659568 | |
| Drug | iodide | ACHE CWC27 ADCY8 FGL2 GLP2R KCNA1 KCNA2 KCNA3 CLCN4 CNTN5 TAP1 MOS APPBP2 IGF2R LRP2 PAM M6PR | 1.03e-04 | 534 | 252 | 17 | CID000024841 |
| Drug | LY97241 | 1.07e-04 | 9 | 252 | 3 | CID000175064 | |
| Drug | NSC21943 | 1.07e-04 | 9 | 252 | 3 | CID000228810 | |
| Drug | Woodward's reagent K | 1.09e-04 | 43 | 252 | 5 | CID000077804 | |
| Drug | amidoxime | 1.10e-04 | 23 | 252 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.10e-04 | 23 | 252 | 4 | CID000066651 | |
| Disease | 5-hydroxyindole sulfate measurement | 2.16e-08 | 5 | 241 | 4 | EFO_0800085 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 2.16e-08 | 5 | 241 | 4 | EFO_0801060 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 2.16e-08 | 5 | 241 | 4 | EFO_0801853 | |
| Disease | neuroblastoma, cutaneous melanoma | 9.04e-08 | 28 | 241 | 6 | EFO_0000389, EFO_0000621 | |
| Disease | X-21339 measurement | 1.49e-07 | 7 | 241 | 4 | EFO_0800808 | |
| Disease | Succinimide measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0022118 | |
| Disease | cholelithiasis, bilirubin measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-24849 measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0800766 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0021260 | |
| Disease | X-11530 measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0801034 | |
| Disease | X-11522 measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0800692 | |
| Disease | serum N-desmethylclozapine measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 2.96e-07 | 8 | 241 | 4 | EFO_0600038 | |
| Disease | X-11442 measurement | 5.30e-07 | 9 | 241 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 5.30e-07 | 9 | 241 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 5.30e-07 | 9 | 241 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 5.30e-07 | 9 | 241 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 5.30e-07 | 9 | 241 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 5.30e-07 | 9 | 241 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 5.30e-07 | 9 | 241 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 5.30e-07 | 9 | 241 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 5.30e-07 | 9 | 241 | 4 | EFO_0004570, GO_0009410 | |
| Disease | indole-3-carboxylate measurement | 5.38e-07 | 3 | 241 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 5.38e-07 | 3 | 241 | 3 | EFO_0022216 | |
| Disease | tissue factor measurement | 6.38e-07 | 21 | 241 | 5 | EFO_0010623 | |
| Disease | X-21448 measurement | 8.77e-07 | 10 | 241 | 4 | EFO_0800816 | |
| Disease | X-23974 measurement | 8.77e-07 | 10 | 241 | 4 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 8.77e-07 | 10 | 241 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 8.77e-07 | 10 | 241 | 4 | EFO_0802185 | |
| Disease | histidine betaine (hercynine) measurement | 1.37e-06 | 11 | 241 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.37e-06 | 11 | 241 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.37e-06 | 11 | 241 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | pregnenetriol sulfate measurement | 1.37e-06 | 11 | 241 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.37e-06 | 11 | 241 | 4 | EFO_0600039 | |
| Disease | aldosterone measurement | 1.37e-06 | 11 | 241 | 4 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 2.04e-06 | 12 | 241 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 2.04e-06 | 12 | 241 | 4 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 2.93e-06 | 13 | 241 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 2.93e-06 | 13 | 241 | 4 | EFO_0802007 | |
| Disease | xanthurenate measurement | 3.53e-06 | 29 | 241 | 5 | EFO_0010551 | |
| Disease | response to dolutegravir | 4.21e-06 | 30 | 241 | 5 | EFO_0600017 | |
| Disease | epilepsy (implicated_via_orthology) | 8.37e-06 | 163 | 241 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 9.50e-06 | 17 | 241 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 9.50e-06 | 17 | 241 | 4 | EFO_0800814 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.06e-05 | 6 | 241 | 3 | EFO_0800566 | |
| Disease | angiopoietin-related protein 1 measurement | 1.21e-05 | 18 | 241 | 4 | EFO_0801382 | |
| Disease | vitamin D deficiency | 1.23e-05 | 37 | 241 | 5 | EFO_0003762 | |
| Disease | indoleacetate measurement | 6.19e-05 | 10 | 241 | 3 | EFO_0021015 | |
| Disease | bilirubin measurement | HLA-DQA1 SIPA1L3 ELP6 KCNA4 CNTN5 MIPEP UGT1A10 UGT1A8 UGT1A7 TTC27 UGT1A9 PLA2R1 SOS2 | 7.86e-05 | 442 | 241 | 13 | EFO_0004570 |
| Disease | Cocaine Abuse | 8.65e-05 | 127 | 241 | 7 | C0009171 | |
| Disease | X-24588 measurement | 1.45e-04 | 13 | 241 | 3 | EFO_0800898 | |
| Disease | hearing loss | 2.23e-04 | 67 | 241 | 5 | EFO_0004238 | |
| Disease | non-high density lipoprotein cholesterol measurement | HLA-DQA1 KCNA4 BAIAP2L2 BRWD1 DNAJC13 UGT1A10 UGT1A8 UGT1A7 UGT1A9 DGKZ PRKAG3 IGF2R MYLIP SMARCA4 M6PR SMAD3 | 2.80e-04 | 713 | 241 | 16 | EFO_0005689 |
| Disease | very low density lipoprotein cholesterol measurement | 3.08e-04 | 260 | 241 | 9 | EFO_0008317 | |
| Disease | Intellectual Disability | SETD1A BRWD3 ZNF462 KCNA2 DHCR7 DYNC1H1 IQSEC3 NBEA OSGEP PPP2R5D LRP2 ASTN1 | 3.39e-04 | 447 | 241 | 12 | C3714756 |
| Disease | Cocaine-Related Disorders | 4.10e-04 | 117 | 241 | 6 | C0236736 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 4.49e-04 | 166 | 241 | 7 | EFO_0004530, EFO_0004611 | |
| Disease | COVID-19, mortality | 5.17e-04 | 170 | 241 | 7 | EFO_0004352, MONDO_0100096 | |
| Disease | Nonsyndromic Deafness | 5.39e-04 | 81 | 241 | 5 | C3711374 | |
| Disease | serum gamma-glutamyl transferase measurement | TRPM7 HLA-DQA1 SIPA1L3 TENM2 MET PKD1 ANAPC5 KLB ATRN EML4 UGT1A10 UGT1A8 UGT1A7 DNAJC30 TRIOBP UGT1A9 SYTL4 CSNK2A2 | 5.61e-04 | 914 | 241 | 18 | EFO_0004532 |
| Disease | thyroxine measurement | 6.03e-04 | 83 | 241 | 5 | EFO_0005130 | |
| Disease | Renal Cell Carcinoma | 6.60e-04 | 128 | 241 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 6.60e-04 | 128 | 241 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 6.60e-04 | 128 | 241 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 6.60e-04 | 128 | 241 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 6.60e-04 | 128 | 241 | 6 | C1306837 | |
| Disease | vitamin D measurement, COVID-19 | 6.89e-04 | 49 | 241 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | chronic hepatitis B virus infection | 9.59e-04 | 24 | 241 | 3 | EFO_0004239 | |
| Disease | axial length measurement, refractive error | 9.75e-04 | 6 | 241 | 2 | EFO_0005318, MONDO_0004892 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 9.75e-04 | 6 | 241 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | Cocaine Dependence | 1.01e-03 | 139 | 241 | 6 | C0600427 | |
| Disease | melanoma | 1.04e-03 | 248 | 241 | 8 | C0025202 | |
| Disease | hearing impairment | 1.28e-03 | 98 | 241 | 5 | C1384666 | |
| Disease | urate measurement, spine bone mineral density | 1.30e-03 | 58 | 241 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | narcolepsy-cataplexy syndrome | 1.39e-03 | 59 | 241 | 4 | MONDO_0016158 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.40e-03 | 148 | 241 | 6 | C0279702 | |
| Disease | uric acid measurement | SLC17A3 TRPM7 HLA-DQA1 SIPA1L3 ADGRV1 TENM2 FAP KLB VMP1 DNAJC13 TTC27 LRP2 SOS2 | 1.64e-03 | 610 | 241 | 13 | EFO_0004761 |
| Disease | mammographic density percentage | 1.68e-03 | 29 | 241 | 3 | EFO_0006502 | |
| Disease | facial width measurement | 1.73e-03 | 105 | 241 | 5 | EFO_0007855 | |
| Disease | Chromosomal Instability | 1.80e-03 | 8 | 241 | 2 | C1257806 | |
| Disease | myasthenia gravis (is_implicated_in) | 1.80e-03 | 8 | 241 | 2 | DOID:437 (is_implicated_in) | |
| Disease | triacylglycerol 58:6 measurement | 1.80e-03 | 8 | 241 | 2 | EFO_0010440 | |
| Disease | urate measurement, bone density | TM9SF3 TENM2 CLVS1 SHC3 GLP2R A2ML1 MIPEP UGT1A10 UGT1A8 UGT1A7 UGT1A9 SNX29 CSNK2A2 | 1.86e-03 | 619 | 241 | 13 | EFO_0003923, EFO_0004531 |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.21e-03 | 111 | 241 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.30e-03 | 220 | 241 | 7 | EFO_0004529, EFO_0008317 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 2.30e-03 | 9 | 241 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Hepatocellular carcinoma | 2.30e-03 | 9 | 241 | 2 | cv:C2239176 | |
| Disease | HEPATOCELLULAR CARCINOMA | 2.30e-03 | 9 | 241 | 2 | 114550 | |
| Disease | metabolite measurement | SETD1A CFAP251 CLTCL1 SLC17A3 ZNF462 TAP1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 IGF2R ENPEP | 2.34e-03 | 560 | 241 | 12 | EFO_0004725 |
| Disease | IGF-1 measurement | WDR76 ZNF462 KLB VMP1 ARRDC5 DNAJC30 DGKZ AKR1C8 IGF2R ASTN1 SMAD3 | 2.40e-03 | 488 | 241 | 11 | EFO_0004627 |
| Disease | panic disorder | 2.45e-03 | 33 | 241 | 3 | EFO_0004262 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.87e-03 | 229 | 241 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | diffuse scleroderma (is_implicated_in) | 3.48e-03 | 11 | 241 | 2 | DOID:1580 (is_implicated_in) | |
| Disease | uveitis (implicated_via_orthology) | 3.48e-03 | 11 | 241 | 2 | DOID:13141 (implicated_via_orthology) | |
| Disease | free androgen index | 3.82e-03 | 374 | 241 | 9 | EFO_0007005 | |
| Disease | heel bone mineral density, urate measurement | 3.93e-03 | 182 | 241 | 6 | EFO_0004531, EFO_0009270 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QYAVSLVDALLFIHY | 221 | Q8TAA9 | |
| AQGARVYAYVFEHRA | 451 | P22303 | |
| YIHRYENVSILFADV | 406 | P40145 | |
| VYAGLFLRYDNLNHS | 876 | P40145 | |
| AVFYHGQQLEYTARL | 911 | P40145 | |
| SFDRYLNIVHATQLY | 146 | P49682 | |
| VAVILYFDVYAQHLA | 26 | O60909 | |
| DVGFRHIDSAYLYQN | 46 | Q5T2L2 | |
| YVDRIIFHENYNAGT | 411 | P05156 | |
| VALFLYHVVFGIQYL | 501 | Q9P2K9 | |
| VGAFQYYQLHKVNIS | 341 | Q9Y646 | |
| VFNYGNHLKERIDQY | 1351 | Q9BXX2 | |
| EAYYDNTIFHRVVPG | 46 | Q6UX04 | |
| FTQAEVYAGNILYEH | 1646 | Q6UVK1 | |
| YSRFDVIHLAAQQTY | 396 | Q9UGI9 | |
| TEEVFRSYVFYRHQQ | 31 | Q16611 | |
| LILIDYGHFQYNSVS | 156 | Q9Y672 | |
| DVIRFDVNTHVYYFA | 1656 | Q7Z2Y8 | |
| FDLIGYAYSHQINIV | 301 | A8K2U0 | |
| GALDYVHVFYTISQI | 1601 | Q8WXG9 | |
| YAHFLNVQGRTLYDV | 96 | Q5T440 | |
| DINLVDVYGNTALHY | 131 | Q9BXX3 | |
| SLIQAQRDYFGAHTY | 441 | P52209 | |
| VSSPHFQVAERALYY | 411 | Q14738 | |
| LIYFRQGHEAYVRAV | 946 | Q6RI45 | |
| NIFYRFIYETEHHNG | 206 | Q13362 | |
| YFVLQVHYGDISAFR | 161 | P19021 | |
| YFDHDLQSYVLVDQG | 461 | Q8N302 | |
| SIGNYEKVFEYHNVL | 526 | Q92624 | |
| DVFGRTALHYAVYNE | 116 | Q8N2N9 | |
| FGNSRLVLFYVEYHT | 311 | P51793 | |
| AVHRDQSFTYQYKIQ | 236 | Q0PNE2 | |
| QFIATADYYGTLHIL | 776 | Q8IWG1 | |
| VGYYIFRVANHQKDL | 346 | Q9UBM7 | |
| GNNSLVFYSILAIHY | 2876 | Q9H251 | |
| IVADHVASYGVNLYQ | 26 | P01909 | |
| FTAAAYYHLNAVRIQ | 3111 | Q8IZT6 | |
| LLDQFGNHYIQEAIY | 856 | O14525 | |
| LYVSVEVIRLGHSYF | 361 | P98198 | |
| YVCAHTAIIYNVFRN | 276 | Q8TBY9 | |
| VVGYKVFYRQEGHSN | 1006 | O94779 | |
| YKNYTLVTVFGNLHQ | 266 | Q8N1F7 | |
| FFVNYENHVLYPVAS | 576 | Q13613 | |
| GYAFVQYSNERHARA | 56 | Q9UKM9 | |
| RAVFYNSVNGIIFVH | 81 | Q5HYI8 | |
| RHNFFESSLDYVYQI | 171 | O60890 | |
| LYGVEFHYARDQSNN | 216 | P29074 | |
| EHYLVQGRYFLVRDV | 91 | Q9ULE6 | |
| VYFFLHYGRHLVQRQ | 246 | Q6ZNF0 | |
| RYAEYSHFVLGNELN | 231 | O43827 | |
| RDVVYFQARLYHTLG | 711 | Q9UJX4 | |
| ITDVFGRTALHYAVY | 126 | Q5JPF3 | |
| YLNQFYSLEIEGNHL | 36 | Q9H306 | |
| YETFYGEHSLLVQQA | 4416 | Q99102 | |
| IVADHVASYGVNFYQ | 26 | P01906 | |
| TYISSVYHVNIRDNG | 241 | O00476 | |
| VPVIVSNFNYFYHRE | 406 | P16389 | |
| VIVSNFNYFYHRETE | 406 | Q09470 | |
| RQVRHLYGITVFEDY | 411 | Q9NZR2 | |
| ALVHDSRYGRYVATQ | 181 | A6NDP7 | |
| HIYALANVAYQSLRD | 76 | Q9UBC5 | |
| AVDGQHVFEYYHRLR | 321 | Q6DKI2 | |
| TVVFALYAHIQYEGF | 221 | A6NEK1 | |
| VNNVVVRYGHSLALY | 386 | O75882 | |
| FENHINYLRSYLDNI | 251 | P12035 | |
| RLYITVNDFEFHVYN | 126 | Q2LD37 | |
| FHVYNRSDLYGRLQE | 136 | Q2LD37 | |
| AVDGQHVFEYYHRLR | 321 | Q3B8N2 | |
| VDGQHLFEYYHRLRN | 321 | O00182 | |
| VYLGNNYLRAFHALS | 31 | Q6UXY1 | |
| FIQVKQHYGFVLYRT | 406 | P16278 | |
| GDDARIYIVFQYHLI | 126 | Q9P1W3 | |
| ASEVQLHLYGQHYRV | 221 | Q9Y5L3 | |
| VQRGSPQILYQFYHE | 496 | Q96RD9 | |
| YQGAYRGATRVETHF | 121 | Q9H4H8 | |
| YISVYDHQGIFKRNN | 131 | Q96E22 | |
| QQYHLQYLARFDALV | 426 | P55160 | |
| VPVIVSNFNYFYHRE | 476 | P22001 | |
| NFSRYIAYIESQGAH | 26 | O75164 | |
| ATLVYHALGRSDYVQ | 131 | Q6ZV70 | |
| EVYDHARRALYNAGV | 321 | Q8WY64 | |
| HNIYSLVENGSYIVA | 1456 | P98164 | |
| PDHIGFYRVNYEVAT | 621 | Q07075 | |
| NGAVVLAFELYYHTT | 371 | Q32M88 | |
| YYHTTQDLQLFREAG | 381 | Q32M88 | |
| IARYVEGIVHLFYQR | 471 | P18054 | |
| VTNGYNHAILAYAFA | 1121 | Q6IE36 | |
| AHGFRIHDYLYFQVL | 21 | Q9BSG0 | |
| TQVIAYSEHRYRIFG | 136 | Q9NPF4 | |
| DYHVTQLQPYFENGR | 1631 | A7KAX9 | |
| QLFENEYYSHGITLV | 931 | Q9UPP2 | |
| GVAYQHAFLYIRQLA | 371 | Q9Y3T9 | |
| YDVEQLRYQATGLHF | 86 | Q86VI3 | |
| PAHLNIFSEVRVYNY | 791 | O60244 | |
| YHVRLLAYNNIDDGY | 686 | Q2VWP7 | |
| HFSTYGAAVAQNRIY | 36 | P09630 | |
| QNHFGAVRSEERYYI | 441 | Q7Z3B4 | |
| YAGTVTYQVHKFLNR | 151 | Q96JP2 | |
| HFYEARFSNLYVGTN | 66 | Q14112 | |
| FYLFHVQEVNGLYRA | 371 | O60906 | |
| RYHGFLNTSYHRQEV | 86 | P11117 | |
| SQGQSHVYALYIVAL | 316 | P55085 | |
| IEYFTSQGLQSIYHL | 506 | O15350 | |
| RTIQVSDFVRYHYNG | 161 | O95302 | |
| IQRAYNHYFDLIIIN | 496 | Q9NZW5 | |
| NSFYDQREYIGRSVH | 591 | A6NKT7 | |
| LLFANVSARHYGNYT | 276 | A6NGN9 | |
| RSVQVLLHYFVGANY | 261 | O95838 | |
| YQLFRSLAYIHSQGV | 226 | P49840 | |
| HFANLQRTGQVYYNT | 486 | Q6ISB3 | |
| FYAAQVVLAVQYLHS | 146 | P22612 | |
| VIVSNFNYFYHRETE | 456 | P17658 | |
| IYAVAGRDYHNDLNA | 401 | Q53GT1 | |
| NFVYVAGGQHLQYRS | 361 | Q53HC5 | |
| IYSFNFHVVKVYNRQ | 111 | P23435 | |
| RVLVAAYLFQTGYGH | 461 | Q96PB1 | |
| IAYGFLFHQDAYLRS | 106 | Q13698 | |
| VYSDGQRRHFIIQYV | 496 | P16591 | |
| AGNLRDVVYTYHQFI | 1521 | Q5SYB0 | |
| YKFRVIAINHYGESF | 791 | Q4KMG0 | |
| IFAIRRHYFNEIGQY | 311 | Q7Z4T8 | |
| YRLRAFGHYFNDTLV | 291 | P0DN25 | |
| VSSYAFRYHNVGILV | 191 | P27544 | |
| VDYIHIFGQGQRYLN | 81 | A8MV24 | |
| EFYHPAQEYNVRVAS | 181 | P19784 | |
| IYFRQGHEAYIEAVR | 966 | Q9NSI6 | |
| FYYRFGQDHARSNLI | 761 | O75165 | |
| LSVLGINYQQFLRHY | 146 | Q8N6I1 | |
| VDQYFYGIKNDIQHA | 81 | O00754 | |
| VANEFLKYRLHVGNY | 321 | Q14314 | |
| KEFISYNINIDIHYG | 96 | Q14204 | |
| AHYYKQIIRENGFSL | 496 | Q86Z14 | |
| NSILVYVGHEVFENY | 606 | Q68CP4 | |
| VTHVYNYDFPRNIDV | 536 | Q86TM3 | |
| RHTETQRPFVFNYYE | 31 | A6NC97 | |
| AIRSQYAHYFDLSLV | 421 | Q00013 | |
| VVVLFNYEERTQRHY | 291 | Q9HC35 | |
| AVGSHDNFIYLYVVS | 691 | Q9HC35 | |
| RSNLFYTQIGEIVYH | 691 | Q05BV3 | |
| RNNLFYTQAGEVVYH | 691 | Q6ZMW3 | |
| YTQAGEVVYHIAAVA | 696 | Q6ZMW3 | |
| LVVAGYYHANAAVND | 76 | Q9Y3B6 | |
| HVVGLRYYTGVVNNN | 66 | Q14527 | |
| RYFNEGTVLAHYADV | 691 | Q14527 | |
| ILIEYYLGFTVFQTH | 366 | Q9HAZ1 | |
| FYRIDRAQEHLNYVT | 726 | Q13574 | |
| AFYQAHYGEQLERER | 166 | Q96LL9 | |
| GQAVRYFHSSANYTV | 141 | Q6BAA4 | |
| SVLYISLHRYDNGNF | 886 | Q9UQL6 | |
| IRVGAAADHNYQSYI | 166 | Q9Y613 | |
| RVGFVTYNKVLHFYN | 546 | P53992 | |
| LYHVYSFRNVQQIGI | 606 | O00411 | |
| VPRFNYVNHDFAYTT | 611 | Q6ZTR5 | |
| LVRQLYHLGVVEAYS | 246 | Q08211 | |
| IELSHFNSVSYRNYG | 86 | Q5J8X5 | |
| YASRGTYHVRLEVNN | 1181 | P98161 | |
| YYGLHRFIVDLTVQE | 121 | O43324 | |
| ARQHYALTIFQSIEY | 36 | O14829 | |
| RQNVDYGVPFHQYTL | 46 | Q99983 | |
| GERQHILYAVVAYDL | 281 | P00540 | |
| HIFLGATNYIYVLNE | 61 | P08581 | |
| YRHQDEAVVLSYVNG | 1876 | P11717 | |
| FYNDRLRVGYVINHL | 231 | A6NKG5 | |
| PHYNHTFVYNGVRLE | 576 | Q96C24 | |
| VYNALVAFIRAEYAH | 331 | Q9BW92 | |
| YLASLRGHVAAVYQI | 406 | Q9NVX2 | |
| YSYNEIHNRRVALGI | 111 | P84550 | |
| NSFYDQREYIGRSVH | 591 | Q7Z3J3 | |
| GNYVFNIRHYEISQQ | 146 | Q07890 | |
| AANAFHVYQVYIRIK | 671 | Q8TEQ0 | |
| LGYLKTHAIEFVNYN | 601 | Q15147 | |
| LHHFRILGEEQYNRY | 301 | O60260 | |
| IRFNIHSRYEDYNVI | 586 | Q9H4L7 | |
| PYRSAFYVLEQQHVG | 1631 | Q6P3W6 | |
| YRSAFYVLEQQHVGL | 1876 | Q6P3W6 | |
| QPYRSAFYVLEQQHV | 2606 | Q6P3W6 | |
| PYRSAFYVLEQQHVG | 2851 | Q6P3W6 | |
| YRSAFYVLEQQHVGL | 3096 | Q6P3W6 | |
| ENSRHYIYIENQFFI | 771 | Q13393 | |
| SEYVHQLYILVNGFL | 256 | O14827 | |
| VGHFGVYTRVSQYIE | 431 | P08709 | |
| VIFQQAGERNYHIFY | 286 | Q9Y2K3 | |
| ANVSSYVHFLLNYRN | 11 | Q8WW32 | |
| AVRALNVFHYLTYEG | 2511 | Q8NFP9 | |
| EFQNESRRLYQFHYV | 181 | Q05209 | |
| NFIRVLVSYNVTHLY | 126 | Q9H3S1 | |
| RGLQSYYAVAHAVTE | 726 | P51532 | |
| QFAGKEQTYYQGRHL | 371 | Q92529 | |
| QYSIEHVDLGARYYQ | 491 | O60292 | |
| YYVDTAVRHVLLRQG | 166 | P23396 | |
| QYEHRYLHRQVAAVG | 571 | Q03518 | |
| HLIFFYIIYLVEGQS | 386 | Q96GZ6 | |
| QELYVFNADGIHQYT | 1591 | Q9NT68 | |
| RSAEQAVYHGIDAYF | 386 | Q96SF2 | |
| VVHQAPYFGAEDYRV | 321 | P41252 | |
| NYDVFRYVITHLNRV | 1381 | Q13017 | |
| QNYRLFFKNVTGHYI | 46 | Q9H2U2 | |
| YPTEGNHRVEFNVNY | 161 | Q9GZT8 | |
| YGQETYVRRHVCFQL | 1141 | Q9NZP6 | |
| SQKVYRYDGVHFSVN | 36 | O15047 | |
| AGFVHQLQEYEAIYL | 161 | Q8WUJ0 | |
| AAYYSHLEGARFQEQ | 1691 | O60287 | |
| YHQSFLTVVLNRLGY | 1156 | Q13018 | |
| TEYAVQRNYGFQIHT | 1846 | Q9H2D6 | |
| QRNYGFQIHTKDAVY | 1851 | Q9H2D6 | |
| YYELNNRVGEAFHAS | 276 | Q99717 | |
| YYELNNRVGEAFHAS | 276 | Q15797 | |
| FGFVHDLVLYLYRNN | 781 | P53675 | |
| VSLNLVHGVFYAERY | 11 | Q03692 | |
| HQADAFRLLAQYFQY | 86 | Q8IUQ0 | |
| VHGHFYYIRIATLVQ | 866 | Q9Y2G3 | |
| SRHYQQRFAVILEAY | 706 | P48736 | |
| AEYFRNVDYLLIHGT | 686 | Q12884 | |
| GAIVHYTILNNHVYR | 191 | Q7Z4H8 | |
| SQQAYVLFYIRSHDV | 401 | Q9H9J4 | |
| AFRYTAYLTGRVQVH | 261 | Q96MU6 | |
| KGYFSQEVNISLHYQ | 106 | P23510 | |
| YQYHSLDVIGFLLAV | 481 | Q9HAW8 | |
| LVGYIIRLENAFYEH | 181 | Q7Z392 | |
| VDLIRYTHAANTVVY | 66 | Q6UXN9 | |
| YIYIFRVCREAGNHT | 71 | P20645 | |
| DYRVVNQFARHYQTG | 536 | Q99797 | |
| NGTFFVYHAIYLEEL | 421 | Q12800 | |
| FYQLCGVHQEDVIYL | 311 | Q5K4L6 | |
| VAHLGYLNYTQYTVI | 271 | Q9P2C4 | |
| SYYELNQRVGETFHA | 236 | P84022 | |
| ISFDGSYVNYRHLAL | 1386 | P24928 | |
| AAGYNRVSVVEYLLH | 691 | O95271 | |
| DYKVAYVQLAHGQTF | 91 | Q16540 | |
| DYRLHHVVVYFIQNQ | 801 | Q9UHP3 | |
| LYIFDINGTHQYTVS | 1521 | Q9P273 | |
| RVSQDGQFLHYIFPY | 166 | Q9HBU9 | |
| SLFLQRYYQVVHEGA | 231 | Q9Y4R7 | |
| VIFGHLAASQLQYYV | 1651 | O00507 | |
| YQYHSLDVIGFLLAV | 481 | O60656 | |
| VAGVLAHVYYQRLSD | 106 | A1L157 | |
| LVADVHQYFYRRTGV | 431 | Q96JH7 | |
| HFAAGYNRVSVVEYL | 531 | Q9H2K2 | |
| YNRVSVVEYLLQHGA | 536 | Q9H2K2 | |
| FINFIAIYYHASRAI | 376 | Q9HD45 | |
| GIIEALHRYYQNAAT | 321 | Q96AP4 | |
| RQYFITAGLRDTHIY | 461 | Q9H967 | |
| YYHRANEQVQVGVEF | 221 | Q969M1 | |
| YSNRSVVGVLVHYQK | 1121 | Q96JM2 | |
| SQNRYVGYFAQVKHL | 371 | Q6XPS3 | |
| LLTYNDFAVHCYRQG | 331 | Q8NEE8 | |
| NHSVYVGDALLYAIR | 91 | Q9UL62 | |
| VINYAHITYKNRSQG | 146 | Q8N7C4 | |
| GRYLAIQFHLECAYV | 226 | Q6P3X3 | |
| YHYITSYVVDGQINI | 76 | Q15238 | |
| LVDHQYNIYLYREGV | 206 | Q8NG68 | |
| FRDIYYRGQTALHIA | 231 | Q9HBA0 | |
| NAYDNHVFVAGRLIY | 951 | Q96QT4 | |
| YILFYTQRVTENGHS | 671 | Q9H0E7 | |
| QYVERHFNKTGQRVY | 56 | P45974 | |
| LTQYFISGRHLYELN | 556 | P35125 | |
| YQYHSLDVIGFLLAV | 481 | Q9HAW7 | |
| YQYHSLDVIGFLLAV | 481 | Q9HAW9 | |
| NSAFARYPNGVVVHY | 861 | Q96JC1 | |
| ATYYVEGVHQQYVQR | 91 | Q96GC9 | |
| SGYFRALLIHYIQDS | 46 | Q8NAP8 | |
| VPVIVSNFNYFYHRE | 556 | P22459 | |
| NFHIYYQLLEGASQE | 206 | O00160 | |
| QILASHYQDVTVYLG | 1951 | Q9NR99 | |
| YNRFVVHGLTTGEQY | 666 | P54296 | |
| LINVIHAFQYVIYGT | 61 | P60201 | |
| YLNIAEYFINHGASV | 136 | O60237 | |
| RFAGYIEKVHYLEQQ | 111 | P07197 |